Golden Ally Lifetech (AQPW) 10-Q 21 Nov 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Nov. 14, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	000-51185
Entity Registrant Name	Golden Ally Lifetech Group, Inc.
Entity Central Index Key	0001317833
Entity Tax Identification Number	16-1732674
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	901 S. Mopack Exp Building 1
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Austin
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	78746
City Area Code	(512)
Local Phone Number	430-1553
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		8,496,061,902

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current
Cash	$ 1,426,467	$ 2,999,370
Prepaids	280,471
Loan receivable - related party	1,000,000
Total Current Assets	2,706,938	2,999,370
Right of use asset	115,175
Goodwill	1,777,204
Total Assets	4,599,317	2,999,370
Current Liabilities
Accounts payable and accrued liabilities	22,124
Lease liabilities	67,939
Due to related parties	5,000	5,000
Total Current liabilities	95,063	5,000
Lease liability, net of current portion	49,026
Total Liabilities	144,089	5,000
Stockholders’ Equity
Convertible Series A Preferred Stock, par value $0.00001: 1,000,000,000 authorized; 1,000,000,000 and 5,000,000 outstanding	10,000	50
Common Stock, par value $0.00001; 10,000,000,000 authorized; 8,496,061,902, and 20,535,982 outstanding	84,961	205
Additional paid-in capital	9,402,893	3,051,685
Accumulated deficit	(5,042,626)	(57,570)
Total Stockholders’ Equity	4,455,228	2,994,370
Total Liabilities and Stockholders’ Equity	$ 4,599,317	$ 2,999,370

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	10,000,000,000	10,000,000,000
Common stock, shares issued	8,496,061,902	20,535,982
Common stock, shares outstanding	8,496,061,902	20,535,982
Convertible Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	1,000,000,000	1,000,000,000
Preferred Stock, shares issued	1,000,000,000	5,000,000
Preferred Stock, shares outstanding	1,000,000,000	5,000,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating Expenses
General and administrative	$ 54,218		$ 212,266
Professional fees	926,213		3,427,745
Research and development			18,450
Wages and salaries	438,037		1,326,595
Total Operating Expenses	1,418,468		4,985,056
Net operating loss	(1,418,468)		(4,985,056)
Income tax
Net Loss	$ (1,418,468)		$ (4,985,056)
Loss per Common Share	$ 0		$ 0
Weighted Average Common Shares Outstanding	8,475,525,920	20,535,982	5,526,167,083	20,535,982

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member] Convertible Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2020
Beginning balance, shares at Dec. 31, 2020
Net loss
Ending balance, value at Sep. 30, 2021
Ending balance, shares at Sep. 30, 2021
Beginning balance, value at Dec. 31, 2021	$ 50	$ 205	3,051,685	(57,570)	2,994,370
Beginning balance, shares at Dec. 31, 2021	5,000,000	20,535,982
Stock subscription received			5,042,060		5,042,060
Recapitalization (reverse merger)			1,777,204		1,777,204
Issuance of stock	$ 9,950	$ 84,755	(94,705)
Issuance of stock, shares	995,000,000	8,475,525,920
Share exchange (reverse merger)			(373,350)		(373,350)
Net loss				(4,985,056)	(4,985,056)
Ending balance, value at Sep. 30, 2022	$ 10,000	$ 84,961	$ 9,402,893	$ (5,042,626)	$ 4,455,228
Ending balance, shares at Sep. 30, 2022	1,000,000,000	8,496,061,902

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (4,985,056)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of ROU asset	23,035
Payment of lease lability	(21,245)
Prepaids	(280,471)
Accounts payable and accrued liabilities and other	22,124
Net cash used in Operating Activities	(5,241,613)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common shares	5,042,060
Net cash provided by Financing Activities	5,042,060
CASH FLOWS FROM INVESTING ACTIVITIES
Share exchange (reverse merger)	(373,350)
Loan receivable - related party	(1,000,000)
Net cash provided by Investing Activities	(1,373,350)
Inflow of Cash	(1,572,903)
Cash - Beginning of period	2,999,370
Cash - End of period	1,426,467
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes
Cash paid for interest
NON CASH INVESTING AND FINANCING ACTIVITIES:
Value of shares not exchanged in reverse merger	$ 1,403,854

BUSINESS

BUSINESS	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BUSINESS	NOTE 1 – BUSINESS Golden Ally Lifetech Group, Inc. (“Golden Ally”) is a Delaware corporation incorporated on December 1, 2020, and operates out of Austin, Texas. Golden Ally is a start-up focusing on a unique product offering. Golden Ally activities to date have focused on the development and exploration of water filtration technology and consumer products with Aquaporin (“AQP”) Bottled Water. Golden Ally has been working with field experts and research institutions to apply and explore the ability to enhance water filtration for improved body cell absorption in commercialized water products. On April 06, 2022, Golden Ally closed on the Share Purchase and Exchange Agreement (“SPA”) with Signet International Holdings, Inc. (“Signet”), a Delaware corporation formed on February 2, 2005, and the Signet Controlling Shareholders. Under generally accepted accounting principles, the acquisition by Signet of Golden Ally is considered to be a capital transaction in substance, rather than a business combination. That is, the acquisition is equivalent to the acquisition by Golden Ally of Signet with the issuance of stock by Golden Ally for the net assets of Signet. This transaction is reflected as a recapitalization and is accounted for as a change in capital structure. Accordingly, the accounting for the acquisition is identical to that resulting from a reverse acquisition. Under reverse merger accounting, the comparative historical financial statements of Signet, as the legal acquirer, are those of the accounting acquirer, Golden Ally. Accordingly, Golden Ally’s financial statements prior to the closing of the reverse acquisition, reflect only the business of Golden Ally. Under the SPA, the Controlling Shareholders of Signet agreed to sell to the Company their capital stock of the Company, consisting of 5,000,000 50,000,000 4,474,080 375,000 In March 2022 Signet’s Board of Directors approved, among other things, an Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, subject to stockholder approval. Stockholder approval was obtained through written consent. Upon approval of all applicable regulatory authorities, Signet’s name was changed from “Signet International Holdings, Inc.” to “Golden Ally Lifetech Group, Inc.”

GOING CONCERN

GOING CONCERN	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN The financial statements have been prepared on a going concern basis which assumes Golden Ally will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. Golden Ally has not yet established a source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. As reflected in the accompanying unaudited condensed financial statements, Golden Ally had a net loss of $ 4,985,056 5,241,613 5,042,626 In order to continue as a going concern, Golden Ally will need, among other things, additional capital resources. Management’s plan is to obtain such resources for Golden Ally by obtaining capital from management and significant shareholders sufficient to meet its minimal operating expenses and seeking third party equity and/or debt financing. Management has held preliminary discussions with potential investors to secure significant capital for Golden Ally in 2022. Management believes that the diversified options for financing potentially available to Golden Ally, along with support from significant shareholders, will allow it to achieve its objectives and satisfy its capital requirements. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should Golden Ally be unable to continue as a going concern.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with GAAP and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q and Article 8 of Regulation S-X. Accordingly, certain information and footnotes required by GAAP in annual financial statements have been omitted or condensed and these interim financial statements should be read in conjunction with the audited financial statements and notes thereto included in Signet’s Information Statement on Schedule 14C, filed with the SEC on March 16, 2022. These condensed financial statements of Golden Ally include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of the Golden Ally’s financial position as of September 30, 2022, and results of its operations and its cash flows for the interim periods presented. The results of operations for the nine months ended September 30, 2022, are not necessarily indicative of the results to be expected for the entire year. There have been no significant changes in the Golden Ally’s accounting policies from those described in the Golden Ally’s audited financial statements and the related notes to those statements. Pursuant to the SPA, the Business Combination was accounted for as a recapitalization in accordance with US GAAP. Under this method of accounting, of Signet International Holdings, Inc., was treated as the acquired company and Golden Ally Lifetech Group, Inc., was treated as the acquirer for financial statement reporting purposes. Golden Ally Lifetech Group, Inc. was determined to be the accounting acquirer based on evaluation of the following facts and circumstances: ● Golden Ally Lifetech Group, Inc., through their ownership of the Convertible Series A Preferred stock and Common Stock, has a 77 ● Golden Ally Lifetech Group, Inc., selected all of the new board of directors of Signet; ● Golden Ally Lifetech Group, Inc., senior management is the senior management of Signet; and ● Golden Ally Lifetech Group, Inc., is the larger entity based on historical operating activity. Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and disclosure at the date of the financial statements. Actual results could differ from those estimates. Management periodically evaluates estimates used in the preparation of the financial statements for continued reasonableness. Actual results and outcomes may differ from management’s estimates and assumptions. Cash and cash equivalents For purposes of the statement of cash flows, Golden Ally considers all highly liquid instruments purchased with an original maturity of three months or less to be cash. As of September 30, 2022, and December 31, 2021, Golden Ally had cash of $ 1,426,467 2,999,370 Concentrations of Credit Risk Golden Ally maintains its cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. Golden Ally continually monitors its banking relationships and consequently has not experienced any losses in its accounts. Management believes Golden Ally is not exposed to any significant credit risk on cash. Loss per Share Loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Golden Ally had no dilutive instruments outstanding during the periods presented. Recent Accounting Pronouncements Golden Ally has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and Golden Ally does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations

PREPAID EXPENSE

PREPAID EXPENSE	9 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSE	NOTE 4 – PREPAID EXPENSE During the nine months ended September 30, 2022, Golden Ally entered into an agreement for legal services and paid $ 750,000 522,983 227,017 During the three months ended September 30, 2022, the Company prepaid for director and officer insurance for a twelve-month period for $ 58,038 3,826 8,410

LOAN RECEIVABLE _ RELATED PARTY

LOAN RECEIVABLE – RELATED PARTY	9 Months Ended
	Sep. 30, 2022
Loan Receivable Related Party
LOAN RECEIVABLE – RELATED PARTY	NOTE 5 – LOAN RECEIVABLE – RELATED PARTY On May 15, 2022, the Company entered into a loan agreement whereby the Company loaned $ 1,000,000

LEASES

LEASES	9 Months Ended
	Sep. 30, 2022
Leases
LEASES	NOTE 6 - LEASES During the nine months ended September 30, 2022, the Company entered into a lease for a location in California. The lease commenced on June 1, 2022 and is for a period of two years . The Company has accounted for the lease in accordance with ASC 842, Leases. Upon commencement of the lease, the Company recorded a right of use asset and lease liability for $ 138,210 . During the nine months ended September 30, 2022, the Company recognized $ 23,035 in amortization, $ 3,955 in interest expense and made payments of $ 25,200 on the lease liability. As at September 30, 2022, the right of use asset was $ 115,175 and the lease lability was $ 116,965 . The discount rate used in the calculation was 10 The principal lease payments are as follows: SCHEDULE OF PRINCIPAL LEASE PAYMENTS 12 Months Ended September 30, 2023 2024 Lease Costs 75,600 50,400 Imputed Interest -7,661 -1,374 Total 67,939 49,026

GOODWILL

GOODWILL	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL	NOTE 7 – GOODWILL Under generally accepted accounting principles, the acquisition by Signet of Golden Ally is considered to be a capital transaction in substance, rather than a business combination. That is, the acquisition is equivalent to the acquisition by Golden Ally of Signet with the issuance of stock by Golden Ally for the net assets of Signet. This transaction is reflected as a recapitalization and is accounted for as a change in capital structure. Accordingly, the accounting for the acquisition is identical to that resulting from a reverse acquisition. Under reverse merger accounting, the comparative historical financial statements of Signet, as the legal acquirer, are those of the accounting acquirer, Golden Ally. As part of the agreement, Golden Ally exchanged 100% of its shares for 77% of Signet shares, representing a premium for the 23% of Signet stock not acquired. 1,777,204 375,000

INVESTMENT _ RELATED PARTY, AND

INVESTMENT – RELATED PARTY, AND ITS SUBSEQUENT RECISSION	9 Months Ended
	Sep. 30, 2022
Investments, All Other Investments [Abstract]
INVESTMENT – RELATED PARTY, AND ITS SUBSEQUENT RECISSION	NOTE 8 – INVESTMENT – RELATED PARTY, AND ITS SUBSEQUENT RECISSION On December 1, 2021, the Company entered into an agreement to purchase 20 2,000,000 2,000,000 On March 7, 2022, the Company entered a recission agreement with Asia Hybrid, and a related party, whereby the original agreement between the Company and Asia Hybrid was rescinded effective December 1, 2021, and both party’s obligations of the agreement were terminated.

CAPITAL STOCK

CAPITAL STOCK	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
CAPITAL STOCK	NOTE 9 – CAPITAL STOCK Common Stock During the nine months ended September 30, 2022, Golden Ally received $ 5,042,060 During the nine months ended September 30, 2022, the Company issued 8,475,525,920 The authorized capital stock consists of 10,000,000,000 0.00001 8,496,525,920 20,535,920 Preferred stock On April 6, 2022, the Company amended the authorized shares of capital preferred stock to 1,000,000,000 0.00001 On April 6, 2022, the Company issued 995,000,000 There were 1,000,000,000 5,000,000 On July 8, 2022, the Company merged its sole subsidiary into the Company. Only the Company exists from this date.

RELATED PARTIES

RELATED PARTIES	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
RELATED PARTIES	NOTE 10 – RELATED PARTIES During the year ended December 31, 2021, a related party paid expenses on behalf of the Company of $ 5,000 5,000 During the nine months ended September 30, 2022 and 2021, the Company paid $ 1,233,964 nil During the nine months ended September 30, 2022, Golden Ally entered into an agreement with a company owned by a related party to develop and implement marketing strategies for Golden Ally’s products. Golden Ally paid $ 2,650,000 per the terms of the agreement for services to be provided, which have been included in Professional fees. The Company does not have any further obligations or commitments to incur additional expenses with this related party. See Note 5 for Loan Receivable – Related Party.

COMMITMENTS

COMMITMENTS	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS	NOTE 11 – COMMITMENTS Operating lease During the nine months ended September 30, 2022, the Company entered into an agreement for office space in Texas. The agreement term is from January 19, 2022, to January 31, 2023 332 During the nine months ended September 30, 2022, the Company entered into a lease for a location in California. The term of the lease was four months ending on May 31, 2022 6,300

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 12 – SUBSEQUENT EVENTS On May 15, 2022, the Company entered into a loan agreement whereby the Company loaned $ 1,000,000 November 14, 2022

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with GAAP and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q and Article 8 of Regulation S-X. Accordingly, certain information and footnotes required by GAAP in annual financial statements have been omitted or condensed and these interim financial statements should be read in conjunction with the audited financial statements and notes thereto included in Signet’s Information Statement on Schedule 14C, filed with the SEC on March 16, 2022. These condensed financial statements of Golden Ally include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of the Golden Ally’s financial position as of September 30, 2022, and results of its operations and its cash flows for the interim periods presented. The results of operations for the nine months ended September 30, 2022, are not necessarily indicative of the results to be expected for the entire year. There have been no significant changes in the Golden Ally’s accounting policies from those described in the Golden Ally’s audited financial statements and the related notes to those statements. Pursuant to the SPA, the Business Combination was accounted for as a recapitalization in accordance with US GAAP. Under this method of accounting, of Signet International Holdings, Inc., was treated as the acquired company and Golden Ally Lifetech Group, Inc., was treated as the acquirer for financial statement reporting purposes. Golden Ally Lifetech Group, Inc. was determined to be the accounting acquirer based on evaluation of the following facts and circumstances: ● Golden Ally Lifetech Group, Inc., through their ownership of the Convertible Series A Preferred stock and Common Stock, has a 77 ● Golden Ally Lifetech Group, Inc., selected all of the new board of directors of Signet; ● Golden Ally Lifetech Group, Inc., senior management is the senior management of Signet; and ● Golden Ally Lifetech Group, Inc., is the larger entity based on historical operating activity.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and disclosure at the date of the financial statements. Actual results could differ from those estimates. Management periodically evaluates estimates used in the preparation of the financial statements for continued reasonableness. Actual results and outcomes may differ from management’s estimates and assumptions.
Cash and cash equivalents	Cash and cash equivalents For purposes of the statement of cash flows, Golden Ally considers all highly liquid instruments purchased with an original maturity of three months or less to be cash. As of September 30, 2022, and December 31, 2021, Golden Ally had cash of $ 1,426,467 2,999,370
Concentrations of Credit Risk	Concentrations of Credit Risk Golden Ally maintains its cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. Golden Ally continually monitors its banking relationships and consequently has not experienced any losses in its accounts. Management believes Golden Ally is not exposed to any significant credit risk on cash.
Loss per Share	Loss per Share Loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Golden Ally had no dilutive instruments outstanding during the periods presented.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Golden Ally has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and Golden Ally does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Sep. 30, 2022
Leases
SCHEDULE OF PRINCIPAL LEASE PAYMENTS	The principal lease payments are as follows: SCHEDULE OF PRINCIPAL LEASE PAYMENTS 12 Months Ended September 30, 2023 2024 Lease Costs 75,600 50,400 Imputed Interest -7,661 -1,374 Total 67,939 49,026

BUSINESS (Details Narrative)

BUSINESS (Details Narrative) - Share Purchase and Exchange Agreement [Member]	9 Months Ended
	Sep. 30, 2022 USD ($) shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of shares issued upon conversion of convertible securities, value | $	$ 375,000
Common Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of shares convertible into common shares	50,000,000
Number of shares issued upon conversion of convertible securities	4,474,080
Series A Convertible Super Preferred Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of shares convertible into common shares	5,000,000

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net Loss	$ 1,418,468		$ 4,985,056
Net cash used in operating activities			5,241,613
Accumulated deficit	$ 5,042,626		$ 5,042,626		$ 57,570

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Percentage of voting interest	77%
Cash	$ 1,426,467	$ 2,999,370

PREPAID EXPENSE (Details Narrat

PREPAID EXPENSE (Details Narrative)	9 Months Ended
	Sep. 30, 2022 USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Prepaid insurance	$ 8,410
Director [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Prepaid insurance	58,038
Officer [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Prepaid insurance	3,826
Legal Service [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Legal fees	750,000
Retainer expenses	522,983
Prepaid expense	$ 227,017

LOAN RECEIVABLE _ RELATED PAR_2

LOAN RECEIVABLE – RELATED PARTY (Details Narrative)	May 15, 2022 USD ($)
Loan Receivable Related Party
Related party loan	$ 1,000,000

SCHEDULE OF PRINCIPAL LEASE PAY

SCHEDULE OF PRINCIPAL LEASE PAYMENTS (Details) - USD ($)	Sep. 30, 2022	Jun. 01, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total	$ 116,965	$ 138,210
12 Months Ended September 30 , 2023 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Lease Costs	75,600
Imputed Interest	(7,661)
Total	67,939
12 Months Ended September 30 , 2024 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Lease Costs	50,400
Imputed Interest	(1,374)
Total	$ 49,026

LEASES (Details Narrative)

LEASES (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Jun. 01, 2022	Dec. 31, 2021
Leases
Lessee, Operating Lease, Term of Contract			2 years
Operating Lease, Liability	$ 116,965		$ 138,210
Operating Lease, Right-of-Use Asset, Amortization Expense	23,035
Operating Lease, Expense	3,955
Operating Lease, Cost	25,200
Operating Lease, Right-of-Use Asset	$ 115,175
Discount rate	10%

GOODWILL (Details Narrative)

GOODWILL (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Business combination description	As part of the agreement, Golden Ally exchanged 100% of its shares for 77% of Signet shares, representing a premium for the 23% of Signet stock not acquired.
Goodwill	$ 1,777,204
Payment for acquisition	$ 375,000

INVESTMENT _ RELATED PARTY, A_2

INVESTMENT – RELATED PARTY, AND ITS SUBSEQUENT RECISSION (Details Narrative) - Asia Hybrid Cryptocurrency Limited [Member]	Dec. 01, 2021 USD ($)
Investment percentage	20%
Payments to acquire investments	$ 2,000,000

CAPITAL STOCK (Details Narrativ

CAPITAL STOCK (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2022	Apr. 06, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock subscriptions	$ 5,042,060
Common stock, shares authorized	10,000,000,000		10,000,000,000
Common stock, par value	$ 0.00001		$ 0.00001
Common stock outstanding	8,496,061,902		20,535,982
Preferred stock shares authorized		1,000,000,000
Preferred stock par value		$ 0.00001
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares issued	1,000,000,000	995,000,000	5,000,000
Preferred stock, shares outstanding	1,000,000,000		5,000,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period	8,475,525,920
Common stock outstanding	8,496,525,920		20,535,920

RELATED PARTIES (Details Narrat

RELATED PARTIES (Details Narrative) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Related Party Transactions [Abstract]
Related party paid expense			$ 5,000
Due to related party	$ 5,000		$ 5,000
Wages and salaries to related parties	1,233,964
Related Party Costs	$ 2,650,000

COMMITMENTS (Details Narrative)

COMMITMENTS (Details Narrative)	9 Months Ended
	Sep. 30, 2022 USD ($)
TEXAS
Product Liability Contingency [Line Items]
Lease term	January 19, 2022, to January 31, 2023
Rent per month	$ 332
CANADA
Product Liability Contingency [Line Items]
Lease term	May 31, 2022
Rent per month	$ 6,300

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative)	May 15, 2022 USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Related party loan	$ 1,000,000
Loan Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Related party loan	$ 1,000,000
Debt instrument, maturity date	Nov. 14, 2022